The global Microfluidic Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microfluidic Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microfluidic Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microfluidic Technology in Biochemical Analysis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microfluidic Technology include Agilent, Fluidigm Corporation, Micralyne, Inc, bioMérieux, Inc., Roche Holdings, Inc., Becton Dickinson, Danaher, PerkinElmer and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microfluidic Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microfluidic Technology.
Report Scope
The Microfluidic Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microfluidic Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microfluidic Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Agilent
Fluidigm Corporation
Micralyne, Inc
bioMérieux, Inc.
Roche Holdings, Inc.
Becton Dickinson
Danaher
PerkinElmer
Bio-Rad Laboratories
Dolomite
908 Devices
MicroLIQUID
MicruX Technologies
Micronit
Fluigent
Micropoint Biotechnologies,Co.,Ltd.
Beijing Bohui Innovation Biotechnology Group Co.,ltd.
Rongzhi Biotechnology(Qingdao) Co., Ltd.
Oxford Nanopore Technologies
Segment by Type
Digital Microfluidics
Capillary Force Driven Microfluidics
Pressure Push Microfluidics
Centrifugal Push Microfluidics
Other
Segment by Application
Biochemical Analysis
Protein Analysis
Cell Biology
Molecular Diagnosis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microfluidic Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Microfluidic Technology Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Digital Microfluidics
1.2.3 Capillary Force Driven Microfluidics
1.2.4 Pressure Push Microfluidics
1.2.5 Centrifugal Push Microfluidics
1.2.6 Other
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Microfluidic Technology Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biochemical Analysis
1.3.3 Protein Analysis
1.3.4 Cell Biology
1.3.5 Molecular Diagnosis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microfluidic Technology Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Microfluidic Technology Growth Trends by Region
2.2.1 Global Microfluidic Technology Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microfluidic Technology Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Microfluidic Technology Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Microfluidic Technology Âé¶¹Ô´´ Dynamics
2.3.1 Microfluidic Technology Industry Trends
2.3.2 Microfluidic Technology Âé¶¹Ô´´ Drivers
2.3.3 Microfluidic Technology Âé¶¹Ô´´ Challenges
2.3.4 Microfluidic Technology Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microfluidic Technology Players by Revenue
3.1.1 Global Top Microfluidic Technology Players by Revenue (2019-2024)
3.1.2 Global Microfluidic Technology Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Microfluidic Technology Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microfluidic Technology Revenue
3.4 Global Microfluidic Technology Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Microfluidic Technology Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microfluidic Technology Revenue in 2023
3.5 Microfluidic Technology Key Players Head office and Area Served
3.6 Key Players Microfluidic Technology Product Solution and Service
3.7 Date of Enter into Microfluidic Technology Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Microfluidic Technology Breakdown Data by Type
4.1 Global Microfluidic Technology Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Microfluidic Technology Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Microfluidic Technology Breakdown Data by Application
5.1 Global Microfluidic Technology Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Microfluidic Technology Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Microfluidic Technology Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Microfluidic Technology Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microfluidic Technology Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Microfluidic Technology Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microfluidic Technology Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Microfluidic Technology Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microfluidic Technology Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Microfluidic Technology Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microfluidic Technology Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Microfluidic Technology Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microfluidic Technology Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Microfluidic Technology Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microfluidic Technology Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Microfluidic Technology Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microfluidic Technology Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Microfluidic Technology Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microfluidic Technology Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Microfluidic Technology Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microfluidic Technology Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Microfluidic Technology Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Detail
11.1.2 Agilent Business Overview
11.1.3 Agilent Microfluidic Technology Introduction
11.1.4 Agilent Revenue in Microfluidic Technology Business (2019-2024)
11.1.5 Agilent Recent Development
11.2 Fluidigm Corporation
11.2.1 Fluidigm Corporation Company Detail
11.2.2 Fluidigm Corporation Business Overview
11.2.3 Fluidigm Corporation Microfluidic Technology Introduction
11.2.4 Fluidigm Corporation Revenue in Microfluidic Technology Business (2019-2024)
11.2.5 Fluidigm Corporation Recent Development
11.3 Micralyne, Inc
11.3.1 Micralyne, Inc Company Detail
11.3.2 Micralyne, Inc Business Overview
11.3.3 Micralyne, Inc Microfluidic Technology Introduction
11.3.4 Micralyne, Inc Revenue in Microfluidic Technology Business (2019-2024)
11.3.5 Micralyne, Inc Recent Development
11.4 bioMérieux, Inc.
11.4.1 bioMérieux, Inc. Company Detail
11.4.2 bioMérieux, Inc. Business Overview
11.4.3 bioMérieux, Inc. Microfluidic Technology Introduction
11.4.4 bioMérieux, Inc. Revenue in Microfluidic Technology Business (2019-2024)
11.4.5 bioMérieux, Inc. Recent Development
11.5 Roche Holdings, Inc.
11.5.1 Roche Holdings, Inc. Company Detail
11.5.2 Roche Holdings, Inc. Business Overview
11.5.3 Roche Holdings, Inc. Microfluidic Technology Introduction
11.5.4 Roche Holdings, Inc. Revenue in Microfluidic Technology Business (2019-2024)
11.5.5 Roche Holdings, Inc. Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Detail
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Microfluidic Technology Introduction
11.6.4 Becton Dickinson Revenue in Microfluidic Technology Business (2019-2024)
11.6.5 Becton Dickinson Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher Microfluidic Technology Introduction
11.7.4 Danaher Revenue in Microfluidic Technology Business (2019-2024)
11.7.5 Danaher Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Detail
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Microfluidic Technology Introduction
11.8.4 PerkinElmer Revenue in Microfluidic Technology Business (2019-2024)
11.8.5 PerkinElmer Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Microfluidic Technology Introduction
11.9.4 Bio-Rad Laboratories Revenue in Microfluidic Technology Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Dolomite
11.10.1 Dolomite Company Detail
11.10.2 Dolomite Business Overview
11.10.3 Dolomite Microfluidic Technology Introduction
11.10.4 Dolomite Revenue in Microfluidic Technology Business (2019-2024)
11.10.5 Dolomite Recent Development
11.11 908 Devices
11.11.1 908 Devices Company Detail
11.11.2 908 Devices Business Overview
11.11.3 908 Devices Microfluidic Technology Introduction
11.11.4 908 Devices Revenue in Microfluidic Technology Business (2019-2024)
11.11.5 908 Devices Recent Development
11.12 MicroLIQUID
11.12.1 MicroLIQUID Company Detail
11.12.2 MicroLIQUID Business Overview
11.12.3 MicroLIQUID Microfluidic Technology Introduction
11.12.4 MicroLIQUID Revenue in Microfluidic Technology Business (2019-2024)
11.12.5 MicroLIQUID Recent Development
11.13 MicruX Technologies
11.13.1 MicruX Technologies Company Detail
11.13.2 MicruX Technologies Business Overview
11.13.3 MicruX Technologies Microfluidic Technology Introduction
11.13.4 MicruX Technologies Revenue in Microfluidic Technology Business (2019-2024)
11.13.5 MicruX Technologies Recent Development
11.14 Micronit
11.14.1 Micronit Company Detail
11.14.2 Micronit Business Overview
11.14.3 Micronit Microfluidic Technology Introduction
11.14.4 Micronit Revenue in Microfluidic Technology Business (2019-2024)
11.14.5 Micronit Recent Development
11.15 Fluigent
11.15.1 Fluigent Company Detail
11.15.2 Fluigent Business Overview
11.15.3 Fluigent Microfluidic Technology Introduction
11.15.4 Fluigent Revenue in Microfluidic Technology Business (2019-2024)
11.15.5 Fluigent Recent Development
11.16 Micropoint Biotechnologies,Co.,Ltd.
11.16.1 Micropoint Biotechnologies,Co.,Ltd. Company Detail
11.16.2 Micropoint Biotechnologies,Co.,Ltd. Business Overview
11.16.3 Micropoint Biotechnologies,Co.,Ltd. Microfluidic Technology Introduction
11.16.4 Micropoint Biotechnologies,Co.,Ltd. Revenue in Microfluidic Technology Business (2019-2024)
11.16.5 Micropoint Biotechnologies,Co.,Ltd. Recent Development
11.17 Beijing Bohui Innovation Biotechnology Group Co.,ltd.
11.17.1 Beijing Bohui Innovation Biotechnology Group Co.,ltd. Company Detail
11.17.2 Beijing Bohui Innovation Biotechnology Group Co.,ltd. Business Overview
11.17.3 Beijing Bohui Innovation Biotechnology Group Co.,ltd. Microfluidic Technology Introduction
11.17.4 Beijing Bohui Innovation Biotechnology Group Co.,ltd. Revenue in Microfluidic Technology Business (2019-2024)
11.17.5 Beijing Bohui Innovation Biotechnology Group Co.,ltd. Recent Development
11.18 Rongzhi Biotechnology(Qingdao) Co., Ltd.
11.18.1 Rongzhi Biotechnology(Qingdao) Co., Ltd. Company Detail
11.18.2 Rongzhi Biotechnology(Qingdao) Co., Ltd. Business Overview
11.18.3 Rongzhi Biotechnology(Qingdao) Co., Ltd. Microfluidic Technology Introduction
11.18.4 Rongzhi Biotechnology(Qingdao) Co., Ltd. Revenue in Microfluidic Technology Business (2019-2024)
11.18.5 Rongzhi Biotechnology(Qingdao) Co., Ltd. Recent Development
11.19 Oxford Nanopore Technologies
11.19.1 Oxford Nanopore Technologies Company Detail
11.19.2 Oxford Nanopore Technologies Business Overview
11.19.3 Oxford Nanopore Technologies Microfluidic Technology Introduction
11.19.4 Oxford Nanopore Technologies Revenue in Microfluidic Technology Business (2019-2024)
11.19.5 Oxford Nanopore Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Agilent
Fluidigm Corporation
Micralyne, Inc
bioMérieux, Inc.
Roche Holdings, Inc.
Becton Dickinson
Danaher
PerkinElmer
Bio-Rad Laboratories
Dolomite
908 Devices
MicroLIQUID
MicruX Technologies
Micronit
Fluigent
Micropoint Biotechnologies,Co.,Ltd.
Beijing Bohui Innovation Biotechnology Group Co.,ltd.
Rongzhi Biotechnology(Qingdao) Co., Ltd.
Oxford Nanopore Technologies
Ìý
Ìý
*If Applicable.